Literature DB >> 19231187

Phenotypic variability in giant axonal neuropathy.

Meriem Tazir1, Sonia Nouioua, Laurent Magy, Kathrin Huehne, Salima Assami, Andoni Urtizberea, Djamel Grid, Tarik Hamadouche, Bernd Rautenstrauss, Jean-Michel Vallat.   

Abstract

Giant axonal neuropathy (GAN), a severe childhood disorder affecting both the peripheral nerves and the central nervous system, is due to mutations in the GAN gene encoding gigaxonin, a protein implicated in the cytoskeletal functions and dynamics. In the majority of the GAN series reported to date, patients had the classical clinical phenotype characterized by a severe axonal neuropathy with kinky hair and early onset CNS involvement including cerebellar and pyramidal signs. We present 12 patients (6 families) with GAN mutations and different clinical phenotypes. Four families were harbouring an identical homozygous nonsense mutation but with different severe clinical phenotypes, one patient had a novel missense homozygous mutation with a peculiar moderate phenotype and prominent skeletal deformations. The last family (4 patients) harbouring a homozygous missense mutation had the mildest form of the disease. In contrast with recent reported series of patients with typical GAN clinical features, the present series demonstrate obvious clinical heterogeneity.

Entities:  

Mesh:

Year:  2009        PMID: 19231187     DOI: 10.1016/j.nmd.2009.01.011

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  14 in total

1.  Phospholipase A2-activating protein is associated with a novel form of leukoencephalopathy.

Authors:  Tzipora C Falik Zaccai; David Savitzki; Yifat Zivony-Elboum; Thierry Vilboux; Eric C Fitts; Yishay Shoval; Limor Kalfon; Nadra Samra; Zohar Keren; Bella Gross; Natalia Chasnyk; Rachel Straussberg; James C Mullikin; Jamie K Teer; Dan Geiger; Daniel Kornitzer; Ora Bitterman-Deutsch; Abraham O Samson; Maki Wakamiya; Johnny W Peterson; Michelle L Kirtley; Iryna V Pinchuk; Wallace B Baze; William A Gahl; Robert Kleta; Yair Anikster; Ashok K Chopra
Journal:  Brain       Date:  2016-12-21       Impact factor: 13.501

2.  Giant axonal neuropathy: a rare inherited neuropathy with simple clinical clues.

Authors:  Mahesh Kamate; Shashikala Ramakrishna; Shweta Kambali; Anita Mahadevan
Journal:  BMJ Case Rep       Date:  2014-09-12

3.  Novel candidate genes and variants underlying autosomal recessive neurodevelopmental disorders with intellectual disability.

Authors:  Regie Lyn P Santos-Cortez; Valeed Khan; Falak Sher Khan; Zaib-Un-Nisa Mughal; Imen Chakchouk; Kwanghyuk Lee; Memoona Rasheed; Rifat Hamza; Anushree Acharya; Ehsan Ullah; Muhammad Arif Nadeem Saqib; Izoduwa Abbe; Ghazanfar Ali; Muhammad Jawad Hassan; Saadullah Khan; Zahid Azeem; Irfan Ullah; Michael J Bamshad; Deborah A Nickerson; Isabelle Schrauwen; Wasim Ahmad; Muhammad Ansar; Suzanne M Leal
Journal:  Hum Genet       Date:  2018-08-22       Impact factor: 4.132

4.  Giant axonal neuropathy: a multicenter retrospective study with genotypic spectrum expansion.

Authors:  Andoni Echaniz-Laguna; Jean-Marie Cuisset; Lucie Guyant-Marechal; Patrick Aubourg; Laurent Kremer; Naziha Baaloul; Alain Verloes; Kouider Beladgham; Jimmy Perrot; Bruno Francou; Philippe Latour
Journal:  Neurogenetics       Date:  2019-10-26       Impact factor: 2.660

5.  Whole-exome sequencing in patients with inherited neuropathies: outcome and challenges.

Authors:  Maria Schabhüttl; Thomas Wieland; Jan Senderek; Jonathan Baets; Vincent Timmerman; Peter De Jonghe; Mary M Reilly; Karl Stieglbauer; Eva Laich; Reinhard Windhager; Wolfgang Erwa; Slave Trajanoski; Tim M Strom; Michaela Auer-Grumbach
Journal:  J Neurol       Date:  2014-03-15       Impact factor: 4.849

6.  Sensory-motor deficits and neurofilament disorganization in gigaxonin-null mice.

Authors:  Thibault Ganay; Alexia Boizot; Renaud Burrer; Jean Paul Chauvin; Pascale Bomont
Journal:  Mol Neurodegener       Date:  2011-04-12       Impact factor: 14.195

7.  Novel homozygous missense mutation in GAN associated with Charcot-Marie-Tooth disease type 2 in a large consanguineous family from Israel.

Authors:  Sharon Aharoni; Katy E S Barwick; Rachel Straussberg; Gaurav V Harlalka; Yoram Nevo; Barry A Chioza; Meriel M McEntagart; Aviva Mimouni-Bloch; Michael Weedon; Andrew H Crosby
Journal:  BMC Med Genet       Date:  2016-11-16       Impact factor: 2.103

8.  Giant Axonal Neuropathy: Clinical, Radiological, and Genetic Features.

Authors:  Meenal Garg; Shilpa D Kulkarni; Anaita Udwadia Hegde; Margi Desai; Rafat J Sayed
Journal:  Ann Indian Acad Neurol       Date:  2018 Oct-Dec       Impact factor: 1.383

9.  Giant axonal neuropathy: cross-sectional analysis of a large natural history cohort.

Authors:  Diana X Bharucha-Goebel; Gina Norato; Dimah Saade; Eduardo Paredes; Victoria Biancavilla; Sandra Donkervoort; Rupleen Kaur; Tanya Lehky; Margaret Fink; Diane Armao; Steven J Gray; Melissa Waite; Sarah Debs; Gilberto Averion; Ying Hu; Wadih M Zein; A Reghan Foley; Minal Jain; Carsten G Bönnemann
Journal:  Brain       Date:  2021-11-29       Impact factor: 15.255

10.  Giant Axonal Neuropathy with Unusual Neuroimagings Caused by Compound Heterozygous Mutations in GAN Gene.

Authors:  Shuang Cai; Jie Lin; Yi-Qi Liu; Jia-Hong Lu; Chong-Bo Zhao
Journal:  Chin Med J (Engl)       Date:  2018-10-05       Impact factor: 2.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.